Hedge Fund Drops Million in Crinetics: Is It a Buy?
A major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
Transform your budget into a powerful savings tool with these optimization techniques. Improve your financial situation now!
18,983 articlesA major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
A mid-sized fund has quietly built a sizable Porch Group position, signaling conviction in this tech-insurance combo....
Think AI stocks can’t deliver both growth and income? This piece reveals two surprising dividend plays that tap AI tr...
Two very different retail giants compete for investors' attention in 2026. This guide breaks down whether Abercrombie...
SpaceX sits at the frontier of aerospace and opportunity. This article breaks down the bold bets, the potential rewar...
When a CEO discloses a sale of 41,600 shares, investors pay attention. This article unpacks the implications, the mec...
Asana has fallen from pandemic highs, but buying the dip isn’t a guaranteed win. This guide explains the risks, what ...
Rivian has faced volatility, with a notable pullback this year. This guide breaks down what’s driving the moves, what...
On a day of mixed signals, Bank of America and peers moved as tariffs and earnings chatter swirled. This article brea...
This week brought a sharp pullback in precious metals equities. We break down what drove the move, how it affects New...
CoreWeave surged after its IPO, then pulled back dramatically. This guide explains what happened, what the company do...
A leading home improvement stock fell 40% last quarter as growth cooled, triggering a $14 million trimming of a major...